Content
section 1 of this Act contains provisions on the
1. advertising of infant formulae and
follow-on formulae, and
2. use of infant formula donated or
sold at preferential prices to health care and
social services.
Expression in law
2 for the purposes of this Act, section
infants: children younger than 12 months,
infant formulae means foodstuffs intended especially as
nutrition for babies during the first few months and which alone
meet the nutritional requirements of infants until they start to get
appropriate complementary feeding,
follow-on formulae means foodstuffs intended particular nutritional
for infants when they begin to receive appropriate complementary feeding and which is
the principal liquid element in an increasingly varied
diet for such infants.
Ban on the marketing of breast-milk substitutes
paragraph 3 of the marketing of breast-milk substitutes are only
allowed in publications that are particularly focused on
baby care and scientific publications. All other
marketing of breast-milk substitutes are forbidden.
Marketing of products other than infant formula
4 § products other than infant formula may not at
marketing be portrayed as suited to solo cater
healthy babies ' nutritional needs during the first few months until
they begin to receive appropriate complementary feeding.
Advertising of infant formulae and follow-on formulae
paragraph 5 of the marketing of breast-milk substitutes and
follow-on formulae shall provide the necessary information about the product
use and shall not discourage from breastfeeding.
Expressions which may give the impression that the products originate from
or have the same characteristics as breast milk must not be used
in the marketing.
Infant formulae and follow-on formulae shall be at
marketing be labeled so that products cannot be
confused with each other.
section 6 of the marketing of breast-milk substitutes may only
contain the nutritional and health claims set out in the annex
to this Act and only under the conditions set out in the annex
are met.
In the case of follow-on formulae provided for nutritional
and health claims of European Parliament and Council
Regulation (EC) No 1924/2006 of 20 december 2006 on
nutrition and health claims made on foods.
Specific provisions relating to the marketing of
infant formula
section 7 of the marketing of breast-milk substitutes may only
contain scientific and factual information. Information
must not imply or convey the impression that breeding with
infant formula is equivalent to or better than
breastfeeding.
section 8 in respect of the marketing of infant formula to the
It should be pointed out that breastfeeding has advantages. It must also state that
the product should only be used on the recommendation of a person
with training in medicine, nutrition or pharmacy, or
anyone else working with infant or maternal health.
section 9 in respect of the marketing of infant formula must not
used pictures of babies or images or texts which may
idealize the use of the product. In the marketing,
However, it used a graphical representation that makes it easy
to identify the product or showing how the product should
be cooked.
Use of infant formula
10 § it is forbidden to health care professionals and
social service use or distribute
infant formula donated or sold to
preferential price other than to children who need it and only
as long as these children need it.
Sanctions under the marketing practices Act
11 § marketing that is contrary to any of paragraphs 3 to 9 shall at the
the application of 5, 23 and 26 of the Marketing Act
(2008:486) is considered to be unfair towards consumers.
Supervision
section 12 of the Swedish consumer agency supervises the application of the provisions
about marketing in this law are complied with.
Annex
Nutrition and health claims for infant formulae and
conditions for the use of such claims
1. NUTRITION CLAIMS
Nutrition claim if the terms and conditions of use
1.1 Only lactose product contains no other
carbohydrate than lactose.
1.2 lactose free Product does not contain more
lactose than 2.5 mg/100 kJ
(10 mg/100 kcal).
1.3 Polyunsaturated fatty acids
has been added, or
the equivalent nutrition claim
in the case of the addition of
Docosahexaenoic Acid Content of Docosahexaenoic acid
less than 0.2% of the
total fatty acid content.
1.4 nutrition claims on the
the addition of the following
Optional ingredients:
1.4.1 Taurine
1.4.2 Fructooligosaccharides
and galaktooligosackarider
1.4.3 Nucleotides Voluntarily added in a variety of
that is appropriate for the intended
special usage and in
accordance with the conditions in question
If mother's milk the
composition that has
provided for under paragraph 6 of 3
the Food Act (2006:804).
2. HEALTH CLAIMS (INCLUDING REDUCTION of DISEASE RISK CLAIMS)
Health claim on terms and conditions for use
2.1 reduced risk of allergy
to milk proteins. This
health claim may include
terms referring to
decreased allergenic or
decreased antigenic properties. a) objective and scientific
coated data that proves the
alleged properties should be
available.
b) infant allowance
comply with the conditions in terms of
mother's milk the
composition that has
provided for under paragraph 6 of 3
the Food Act (2006:804).
The amount of immune reactive protein,
in terms of recognised
methods, should be less than
1 percent of the nitrogen-containing
substances in mother's milk.
(c)) the label shall clearly state the
that this product must not be consumed
of children who are allergic to the
intact proteins it is
produced by such a text.
not needed if generally recognised
clinical trials show that
infant allowance
tolerated by more than 90 per cent
of infants (95%
confidence intervals)
allergic to the protein
which the hydrolysate is produced
by.
d) infant compensation may
When oral administration is not giving
rise to hypersensitivity in
animals to the intact proteins
which the hydrolysate is produced
by.
